Literature DB >> 31758531

The TNF-TNFR Family of Co-signal Molecules.

Takanori So1,2, Naoto Ishii3.   

Abstract

Costimulatory signals initiated by the interaction between the tumor necrosis factor (TNF) ligand and cognate TNF receptor (TNFR) superfamilies promote clonal expansion, differentiation, and survival of antigen-primed CD4+ and CD8+ T cells and have a pivotal role in T-cell-mediated adaptive immunity and diseases. Accumulating evidence in recent years indicates that costimulatory signals via the subset of the TNFR superfamily molecules, OX40 (TNFRSF4), 4-1BB (TNFRSF9), CD27, DR3 (TNFRSF25), CD30 (TNFRSF8), GITR (TNFRSF18), TNFR2 (TNFRSF1B), and HVEM (TNFRSF14), which are constitutive or inducible on T cells, play important roles in protective immunity, inflammatory and autoimmune diseases, and tumor immunotherapy. In this chapter, we will summarize the findings of recent studies on these TNFR family of co-signaling molecules regarding their function at various stages of the T-cell response in the context of infection, inflammation, and cancer. We will also discuss how these TNFR co-signals are critical for immune regulation and have therapeutic potential for the treatment of T-cell-mediated diseases.

Entities:  

Keywords:  4-1BB; CD27; CD30; DR3; GITR; HVEM; OX40; TNFR2; TNFRSF; TNFSF

Mesh:

Substances:

Year:  2019        PMID: 31758531     DOI: 10.1007/978-981-32-9717-3_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  30 in total

Review 1.  The chemical biology of IL-12 production via the non-canonical NFkB pathway.

Authors:  Peter D Koch; Mikael J Pittet; Ralph Weissleder
Journal:  RSC Chem Biol       Date:  2020-07-22

2.  Redistribution of TNF Receptor 1 and 2 Expression on Immune Cells in Patients with Bronchial Asthma.

Authors:  Alina Alshevskaya; Julia Zhukova; Fedor Kireev; Julia Lopatnikova; Irina Evsegneeva; Daria Demina; Vera Nepomniashchikch; Victor Gladkikh; Alexander Karaulov; Sergey Sennikov
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

Review 3.  Lymphotoxins Serve as a Novel Orchestrator in T1D Pathogenesis.

Authors:  Shi-Wei Liu; Fei Sun; Shan-Jie Rong; Ting Wang; Cong-Yi Wang
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

4.  MST4 Regulates Epithelial-Mesenchymal Transition of Choriocarcinoma by Mediating TGF-β1 Expression.

Authors:  Hanxi Yu; Weichen Zhang; Peilin Han; Beng Yang; Xiaode Feng; Ping Zhou; Xiaoxu Zhu; Bingqian Zhou; Wei Chen; Jianhua Qian; Jun Yu
Journal:  Onco Targets Ther       Date:  2020-11-19       Impact factor: 4.147

5.  Dissecting the Role of Immune Checkpoint Regulation Patterns in Tumor Microenvironment and Prognosis of Gastric Cancer.

Authors:  Zili Zhen; Zhemin Shen; Peilong Sun
Journal:  Front Genet       Date:  2022-04-19       Impact factor: 4.772

Review 6.  B-Cell Maturation Antigen (BCMA) as a Target for New Drug Development in Relapsed and/or Refractory Multiple Myeloma.

Authors:  Hanley N Abramson
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

Review 7.  Recent Advances in Allogeneic CAR-T Cells.

Authors:  Dong Wook Kim; Je-Yoel Cho
Journal:  Biomolecules       Date:  2020-02-10

8.  A Poorly Differentiated Non-keratinizing Sinonasal Squamous Cell Carcinoma with a Novel ETV6-TNFRSF8 Fusion Gene.

Authors:  Justin Bubola; Christina M MacMillan; Ilan Weinreb; Ian Witterick; David Swanson; Lei Zhang; Cristina R Antonescu; Brendan C Dickson
Journal:  Head Neck Pathol       Date:  2021-01-04

9.  Tumor Necrosis Factor Receptor-1 (p55) Deficiency Attenuates Tumor Growth and Intratumoral Angiogenesis and Stimulates CD8+ T Cell Function in Melanoma.

Authors:  Yamila I Rodriguez; Ludmila E Campos; Melina G Castro; Nadia Bannoud; Ada G Blidner; Verónica P Filippa; Diego O Croci; Gabriel A Rabinovich; Sergio E Alvarez
Journal:  Cells       Date:  2020-11-13       Impact factor: 6.600

Review 10.  T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors.

Authors:  Nicholas J Chandler; Melissa J Call; Matthew E Call
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.